Researchers at the University of Edinburgh and the UK Dementia Research Institute report that oligodendrocytes, the brain cells that produce the myelin insulating nerve fibers, may become dysfunctional with age and help drive cognitive decline. The study, published in Nature Medicine, challenges the long-held view that these cells are always beneficial.
The work drew on the Lothian Birth Cohort 1936, a group whose thinking abilities have been tracked from childhood into old age. Between ages 70 and 82, participants were assessed for memory, processing speed and spatial reasoning. Of the 1,091 people originally enrolled, 866 completed additional cognitive testing after age 70. Nearly everyone declined at least somewhat, but the rate varied widely, which gave the team a way to compare brains that aged quickly with those that aged more gradually.
After death, brain tissue from a subset of participants showed a consistent pattern. People with faster cognitive decline tended to have fewer large nerve fibers and an abnormal buildup of unhealthy myelin, with the changes most pronounced around the large fibers that remained. These abnormalities tracked how quickly abilities declined rather than how well someone performed at a given age.
The researchers then found that people with more severe decline had lower levels of a protein called NRF2 in their oligodendrocytes. When the team reduced NRF2 specifically in these cells in mice, the animals developed excess myelin, lost large nerve fibers and showed smaller gains in cognitive performance as they aged, closely resembling the human findings. Because NRF2 is already a drug target, the authors note that a medication used for multiple sclerosis, which acts on this pathway, has been linked in earlier studies to better cognition in people with MS. The authors stress that further research is needed to determine whether such treatments would help older adults with cognitive decline.